Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Current Location:
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

More HCB News

AHRA Product Showcase A few of the solutions that will be on display at the event

The rise of medical device hacking: How strong is your network security? In Q3 of 2018 alone, 4.4 million medical records were compromised

Balancing AI and the human touch with two new approaches Technology shouldn't sacrifice the clinician-patient relationship

Patients like the idea of telemedicine, but what about physicians? New study examines U.S. physician interest in telemedicine

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Intuitive acquires Schölly Fiberoptic's robotic endoscope business Enhances supply chain, raises manufacturing capacity for imaging devices

Siemens forms $113 million alliance with UM System and MU Health Care The 10-year partnership will focus on improved care delivery and research

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

Misdiagnosis behind a third of malpractice cases Researchers from Johns Hopkins look at 55,000 malpractice claims

Maryland Proton Treatment Center completes first patient treatment with Varian ProBeam

Press releases may be edited for formatting or style
PALO ALTO, Calif., Feb. 23, 2016 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR), today announced the Maryland Proton Treatment Center (MPTC) successfully completed its first patient treatment with the Varian ProBeam® system. The MPTC at the University of Maryland BioPark in West Baltimore houses five treatment rooms and is the first in the Eastern US to offer image-guided intensity-modulated proton therapy (IMPT) with a ProBeam system.

Proton therapy makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than is possible with conventional radiation therapy. With proton therapy, the risk of damage to healthy tissues and potential side effects are reduced because proton beams can be controlled so that they deposit their energy within the tumor site rather than passing all the way through the patient.

Story Continues Below Advertisement

THE (LEADER) IN MEDICAL IMAGING TECHNOLOGY SINCE 1982. SALES-SERVICE-REPAIR

Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.



MPTC is delivering the most precise form of proton therapy using Varian's pencil beam scanning technology. With this technology a proton beam precisely paints a tumor with radiation using a pencil point beam that deposits dose layer by layer as it scans back and forth across the target area. To view a video of pencil beam scanning, visit http://www.varian.com/PencilBeamScanning

In a related press release today from MPTC, titled: At University of Maryland, First Cancer Patients Receive Proton Therapy at New Maryland Proton Treatment Center, William F. Regine, MD, FACR, FACRO, MPTC executive director and the Isadore & Fannie Foxman Schneider Endowed Chair and Professor of Radiation Oncology at the University of Maryland School of Medicine, stated, "We are very pleased and excited to be able to make this form of radiation therapy available to cancer patients in the Baltimore-Washington region and beyond. Proton therapy enables us to deliver a targeted dose of lifesaving radiation therapy directly to the tumor while minimizing radiation to healthy tissue. It can result in a more effective treatment for patients with fewer side effects. This technology is a powerful tool in our toolbox for fighting cancer."

"We are proud to collaborate with the MPTC to bring this advanced cancer-fighting technology to patients in the Baltimore-area as well as around the world. We are pleased that it took only nine months from the the building 'ready for equipment' milestone to the first patient treatment," said Dr. Moataz Karmalawy, general manager of Varian's Particle Therapy division.

Additionally, Varian's ProBeam technology is being used to treat patients at the Scripps Proton Therapy Center in San Diego, the Rinecker Proton Therapy Center in Munich, and at the Paul Scherrer Institute in Switzerland. Varian also has contracts for system installations at 13 other sites around the world.
  Pages: 1 - 2 >>

Related:


You Must Be Logged In To Post A Comment